EMAIL THIS PAGE TO A FRIEND

PloS one

The Accumulation of VEGFA in the Glomerular Basement Membrane and Its Relationship with Podocyte Injury and Proteinuria in Alport Syndrome.


PMID 26274923

Abstract

The pathogenesis of proteinuria in Alport syndrome (AS) remains unclear. Vascular endothelial growth factor A (VEGFA) is a key regulator of the glomerular filtration barrier (GFB). This study explored the expression of VEGFA in the glomeruli and its accumulation in the glomerular basement membrane (GBM) and their relationship with podocyte injury and proteinuria in Alport syndrome (AS). Clinical data and renal tissues of control patients (11 cases) and AS patients (25 cases) were included. AS patients were further divided into 2 groups according to the quantities of their urinary protein: mild to moderate proteinuria group (proteinuria <50 mg/kg/d, 15 cases) and heavy proteinuria group (proteinuria ≥50 mg/kg/d, 10 cases). The expression and distribution of VEGFA and VEGF receptor 2 (VEGFR2) in the GFB, the phosphorylation of VEGFR2 (p-VEGFR2) and nephrin (p-nephrin), and the expression of synaptopodin and nephrin in the glomeruli were detected by immune electron microscopy and/or immunofluorescence, and their relationships to proteinuria in AS patients were analyzed. The accumulation of VEGFA in the GBM was increased in AS patients. The expression of VEGFA and the levels of p-VEGFR2 and p-nephrin in glomeruli were increased and were positively correlated with the degree of proteinuria in AS patients. The expression of synaptopodin and nephrin were decreased and were negatively correlated with the degree of proteinuria in AS patients. The over expressed VEGFA in the glomeruli and its accumulation in the GBM may activate the VEGFA-VEGFR2 and nephrin signaling pathways and lead to podocyte injury and occurrence of proteinuria in AS.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1401519
Anti-TCIRG1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA038742
Anti-TCIRG1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
G5882
Glutaraldehyde solution, Grade I, 25% in H2O, specially purified for use as an electron microscopy fixative
C5H8O2
G7651
Glutaraldehyde solution, Grade I, 50% in H2O, specially purified for use as an electron microscopy fixative or other sophisticated use
C5H8O2
G7776
Glutaraldehyde solution, Grade I, 70% in H2O, specially purified for use as an electron microscopy fixative or other sophisticated use
C5H8O2
G7526
Glutaraldehyde solution, Grade I, 8% in H2O, specially purified for use as an electron microscopy fixative or other sophisticated use
C5H8O2
G6257
Glutaraldehyde solution, Grade II, 25% in H2O
C5H8O2
G6403
Glutaraldehyde solution, 50% in H2O, suitable for photographic applications
C5H8O2
340855
Glutaraldehyde solution, 50 wt. % in H2O
C5H8O2
49626
Glutaraldehyde solution, for electron microscopy, ~25% in H2O
C5H8O2
G4004
Glutaraldehyde solution, 25 wt. % in H2O
C5H8O2
W512303
Glutaric dialdehyde solution, 50 wt. % in H2O, FCC
C5H8O2
H9003
Hydroquinone, ReagentPlus®, ≥99%
C6H6O2
H3660
Hydroquinone, meets USP testing specifications
C6H6O2
H17902
Hydroquinone, ReagentPlus®, ≥99.5%
C6H6O2
WH0010312M1
Monoclonal Anti-TCIRG1 antibody produced in mouse, clone 6H3, purified immunoglobulin, buffered aqueous solution
SAB1404814
Monoclonal Anti-TCIRG1 antibody produced in mouse, clone 6H3, ascites fluid